Skip to main content

Table 1 Descriptive characteristics of 209 breast cancer survivors surveyed about lymphedema

From: Assessing the Impact of Lymphedema Therapy Referral on Breast Cancer Survivors’ Lymphedema Knowledge: A Cross-Sectional Survey

 

Not referred to lymphedema therapy, n = 156

No. (%)

Referred to lymphedema therapy, n = 53

No. (%)

p-value

Age

  

0.02

18–44

32 (21)

17 (32)

 

45–54

41 (26)

9 (17)

 

55–64

38 (24)

20 (38)

 

65+

45 (29)

7 (13)

 

Education

  

0.67

< Bachelor’s

55 (35)

17 (32)

 

Bachelors+

101 (65)

36 (68)

 

Race/Ethnicity

  

0.46

Asian

15 (10)

2 (4)

 

Black

19 (12)

8 (15)

 

Hispanic/Latina

16 (10)

5 (9)

 

White

100 (65)

38 (72)

 

Mixed or other

4 (3)

0 (0)

 

Patient-reported lymphedema diagnosis

  

< 0.01

No

142 (91)

21 (40)

 

Yes

13 (8)

32 (60)

 

Nodal procedure

  

< 0.01

Sentinel lymph node biopsy

96 (62)

15 (28)

 

Axillary lymph node dissection

60 (38)

38 (72)

 

Radiation therapy

  

< 0.01

No

58 (37)

7 (13)

 

Yes

98 (63)

46 (87)

 

Chemotherapy

  

< 0.01

No

57 (37)

7 (13)

 

Yes

99 (63)

46 (87)

 

Surgery

  

0.41

Lumpectomy

73 (48)

22 (42)

 

Mastectomy

79 (52)

31 (58)

 

Time from survey to diagnosis [years, median (IQR)]

3.3 (1.8–5.2)

2.7 (2.1–4.7)

0.75

Lymphedema therapist is info source*

5 (3)

37 (70)

< 0.01

Doctor is info source*

77 (49)

20 (38)

0.14

Nurse is info source*

36 (23)

10 (19)

0.52

Friends, internet, or support group are info source*

38 (24)

19 (35)

0.11

  1. *Participants allowed to select multiple options